For a B2B ingredient, third-party recognition is not a marketing badge — it is part of the evidence layer that R&D, QA, regulatory, and procurement teams use to shortlist suppliers. When an ingredient is evaluated by independent industry juries, the result tells a brand owner something a supplier's own datasheet cannot: how the ingredient holds up against its peers on innovation, science, and market potential.
AKK PROBIO, our Akkermansia muciniphila ingredient (strain CGMCC No.20955), has been evaluated by three independent industry programs over the past two years. This article summarizes what those recognitions are, what each one actually signifies, and where buyers can verify them independently.
Quick Answer
AKK PROBIO has been recognized by three independent industry programs: it is a Finalist for Ingredient of the Year: Microbiome Modulation at the 2026 NutraIngredients USA Awards, the Weight Management winner of the 2025 SupplySide Global Ingredient Idol Award, and a Gold Medal and Special Award recipient at the 2025 iCAN International Innovation Competition (Canada). Each recognition is documented by an independent third party — the awards organizers and our U.S. distribution partner — not solely by AKK PROBIO.
These are distinct programs with different judging criteria. None of them is a regulatory determination, and none should be read as a health claim. They are signals about how the ingredient was assessed on innovation, scientific substantiation, and market relevance by independent industry evaluators.
2026 NutraIngredients USA Awards — Finalist, Ingredient of the Year: Microbiome Modulation
The NutraIngredients USA Awards are among the most established recognition programs in the North American nutrition ingredients industry. The "Ingredient of the Year: Microbiome Modulation" category, run in association with Probiota Americas, evaluates ingredients on scientific evidence and commercial relevance.
AKK PROBIO was named a Finalist in this category in 2026. The independent jury's shortlist for this category included three ingredients; the category winner was FatSlim™ (a Latilactobacillus curvatus HY7601 and Lacticaseibacillus KY1032 mixture, by hy), with AKK PROBIO and Solnul® Prebiotic Resistant Potato Starch (MSP Starch Products) as fellow finalists. Winners were announced on July 13, 2026, in Chicago.
We state this precisely because precision matters to the audience we serve: AKK PROBIO was a finalist, not the category winner. Being shortlisted by an independent scientific jury — alongside a peer group of microbiome-modulating ingredients — is itself a meaningful, verifiable signal, and it is one buyers can confirm directly on the organizer's site.
Independent source: NutraIngredients USA Awards 2026 — finalists and winners announcement.
2025 SupplySide Global Ingredient Idol — Winner, Weight Management
Ingredient Idol is a live-juried innovation competition held at SupplySide Global, one of the largest ingredient trade shows in North America. Ingredients are evaluated on innovation, scientific support, and market potential, with finalists presenting to a panel of industry judges and a live audience.
In 2025, AKK PROBIO was selected as the Weight Management category winner. This recognition is documented independently by our U.S. distribution partner, Maypro, which lists AKK PROBIO as the "Ingredient Idol 2025 Winner" on its product page.
For a formulation audience, the relevance of this award is the judging lens: weight-management ingredients are assessed on whether the supporting science and the mechanism are credible to a technically literate jury, not on consumer-facing marketing.
Independent source: Maypro — AKK PROBIO product page (noting the Ingredient Idol 2025 Winner recognition).
2025 iCAN International Innovation Competition — Gold Medal & Special Award
The iCAN International Innovation Competition (Canada) is an invention and innovation program that evaluates entries on novelty and technical merit. In 2025, AKK PROBIO received a Gold Medal and a Special Award at this competition, recognizing the strain's innovation profile.
Independent source: iCAN 2025 award announcement (PRWeb).
What These Recognitions Do — and Do Not — Mean
We ask buyers to read third-party recognition the same way we do: as one input among several, and never as a substitute for documentation.
These awards tell you how independent industry juries assessed AKK PROBIO on innovation, scientific substantiation, and market relevance. They do not tell you whether the ingredient is right for your formulation, and they are not regulatory approvals or safety determinations. Those rest on a separate, verifiable foundation:
- Regulatory status. AKK PROBIO holds self-affirmed GRAS under 21 CFR §170.30 for both live and pasteurized forms, and the pasteurized form has completed FDA New Dietary Ingredient Notification #1468. (See Regulatory & Safety; independent coverage via GlobeNewswire.)
- Scientific evidence. The strain is supported by 13 peer-reviewed publications and 7 clinical studies, including an 8-week, randomized, double-blind, placebo-controlled human trial. (See Science & Evidence.)
- Commercial availability. AKK PROBIO is distributed in the United States by Maypro (New York). (See Nutraceuticals World.)
Awards sit on top of this foundation. They are a useful screening signal, but the foundation is what your QA and regulatory teams should evaluate.
Evaluating AKK PROBIO for Your Formulation?
If you are shortlisting Akkermansia suppliers, we are glad to provide the documentation behind these recognitions — the strain dossier, regulatory package, specifications, and clinical summaries. Request a sample or talk to our technical team about your application.